Monacolin J
CAS No. 79952-42-4
Monacolin J( Antibiotic MB 530A | Lovastatin diol lactone )
Catalog No. M26303 CAS No. 79952-42-4
Monacolin J is a cholesterol biosynthesis inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 147 | Get Quote |
|
10MG | 222 | Get Quote |
|
25MG | 376 | Get Quote |
|
50MG | 536 | Get Quote |
|
100MG | 777 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMonacolin J
-
NoteResearch use only, not for human use.
-
Brief DescriptionMonacolin J is a cholesterol biosynthesis inhibitor.
-
DescriptionMonacolin J is a cholesterol biosynthesis inhibitor.(In Vitro):Monacolin J is a cholesterol biosynthesis inhibitor, and inhibits the activity of HMG-CoA reductase. Na salt of Monacolin J causes 50% inhibition on reductase at 1.2 μg/mL.
-
In VitroMonacolin J is an inhibitor of cholesterol biosynthesis, and inhibits the activity of HMG-CoA reductase. Na salt of Monacolin J causes 50% inhibition on reductase at 1.2 μg/mL.
-
In Vivo——
-
SynonymsAntibiotic MB 530A | Lovastatin diol lactone
-
PathwayMetabolic Enzyme/Protease
-
TargetHMGCR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number79952-42-4
-
Formula Weight320.42
-
Molecular FormulaC19H28O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (312.09 mM)
-
SMILESO=C1C[C@H](O)C[C@@H](CC[C@H]2[C@@H](C)C=CC3=C[C@H](C)C[C@H](O)[C@]23[H])O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hoesl M, Dietz K, R?cken M, Berneburg M. Vitamin D levels of XP-patients under stringent sun-protection. Eur J Dermatol. 2010 Jul-Aug;20(4):457-60.
molnova catalog
related products
-
Anhydrosimvastatin
Anhydrosimvastatin is an impurity of Simvastatin. Simvastatin is an HMG-CoA reductase inhibitor.
-
Atorvastatin hemical...
A competitive inhibitor of HMG-CoA reductase (HMGCR) that acts as a lipid-lowering agent for prevention of events associated with cardiovascular disease.
-
Clinofibrate
Clinofibrate inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR) with IC50 of 0.47 mM.